Delivery Order SPE2DB22D1106-SPE2DB25FEDC7

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $69K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $20,786.28 firm fixed-price delivery order is for the supply of 4,567,607,451 vials of Artesunate 110 mg, a critical malaria treatment medication. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Artesunate 110 mg vials valued at $17,703.20. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical worth up to $999,999,999 through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award, valued at $32,464.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order classified as Firm Fixed Price, with an ultimate completion date of November 22, 2024. The award is for the supply of Artesunate for Injection, a critical pharmaceutical product. This contract is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $99,734.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of ARTESUNATE FOR INJECT medical products. The contract has a ceiling value of $30,703.79 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,464.96, is for the delivery of ARTESUNATE FOR INJECT medical supplies. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 110 mg vials of the antimalarial medication artesunate. The $53,122 firm fixed-price contract has a completion date of February 14, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This federal contract award is for the delivery of the pharmaceutical product Artesunate for injection. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has a ceiling value of $32,464.96 and runs through November 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation....
This federal contract award, valued at $48,407.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 110 mg vials of Artesunate, a medication used to treat severe malaria. The contract has a ceiling value of $6,869.75 and a period of performance through December 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEDC7
    Delivery Order

This federal contract award, valued at $69,287.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific award is for 4,567,712,167 units of Artesunate 110 mg vials, a critical antimalarial medication. The contract has a firm fixed-price pricing type and an ultimate completion date of March 17, 2025. No set-aside designation was used for this award. Amerisourcebergen's extensive federal contract history and capabilities in supplying a wide array of pharmaceutical and medical commodities to various government agencies, particularly the military, make it well-positioned to fulfill this order efficiently.

Generated 6/13/25, 9:53 AM